- Report
- October 2022
- 200 Pages
Global
From €2813EUR$2,950USD£2,402GBP
- Report
- January 2022
- 200 Pages
Global
From €7151EUR$7,500USD£6,106GBP
- Report
- January 2022
- 60 Pages
Global
From €3766EUR$3,950USD£3,216GBP
- Report
- May 2022
- 51 Pages
Global
From €2336EUR$2,450USD£1,995GBP
- Report
- September 2022
- 46 Pages
Global
From €2336EUR$2,450USD£1,995GBP
- Report
- August 2022
- 60 Pages
Global
From €4719EUR$4,950USD£4,030GBP
- Report
- November 2021
- 73 Pages
Global
From €4719EUR$4,950USD£4,030GBP
- Report
- November 2021
- 43 Pages
Global
- Report
- June 2021
- 77 Pages
Global
From €4719EUR$4,950USD£4,030GBP
- Report
- June 2020
- 65 Pages
Global
- Report
- April 2019
- 15 Pages
Global
- Report
- September 2018
- 15 Pages
Global
- Report
- August 2018
- 15 Pages
Global
- Report
- July 2018
- 15 Pages
Global
- Report
- April 2018
- 15 Pages
Global
- Report
- August 2021
- 197 Pages
Global
From €3037EUR$3,185USD£2,593GBP
€4338EUR$4,550USD£3,704GBP
- Report
- April 2023
- 105 Pages
Global
From €4529EUR$4,750USD£3,867GBP
- Report
- April 2023
- 110 Pages
Global
From €4529EUR$4,750USD£3,867GBP
- Report
- April 2023
- 115 Pages
Global
From €4529EUR$4,750USD£3,867GBP
- Report
- April 2023
- 120 Pages
Global
From €4529EUR$4,750USD£3,867GBP
The mRNA market within the biotechnology industry is a rapidly growing sector that focuses on the development of messenger ribonucleic acid (mRNA) technology. mRNA is a type of genetic material that is used to create proteins and is a key component of gene therapy. mRNA technology has been used to develop treatments for a variety of diseases, including cancer, heart disease, and neurological disorders. mRNA technology has also been used to develop vaccines for infectious diseases.
The mRNA market is driven by the increasing demand for mRNA-based treatments and vaccines, as well as the growing number of applications for mRNA technology. Companies in the mRNA market are focused on developing mRNA-based treatments and vaccines, as well as developing new applications for mRNA technology. Some of the major companies in the mRNA market include Moderna, BioNTech, CureVac, and Arcturus Therapeutics. Show Less Read more